SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-006421
Filing Date
2021-02-17
Accepted
2021-02-17 17:10:10
Documents
15
Effectiveness Date
2021-02-17

Document Format Files

Seq Description Document Type Size
1 S-8 vktx-s8.htm S-8 117739
2 EX-5.1 vktx-ex51_6.htm EX-5.1 26895
3 EX-23.1 vktx-ex231_7.htm EX-23.1 3743
4 GRAPHIC gjhsarxv5ee4000002.jpg GRAPHIC 631
5 GRAPHIC gjhsarxv5ee4000008.jpg GRAPHIC 722
6 GRAPHIC gjhsarxv5ee4000003.jpg GRAPHIC 639
7 GRAPHIC gjhsarxv5ee4000001.jpg GRAPHIC 631
8 GRAPHIC gjhsarxv5ee4000004.jpg GRAPHIC 635
9 GRAPHIC gjhsarxv5ee4000009.jpg GRAPHIC 635
10 GRAPHIC gjhsarxv5ee4000010.jpg GRAPHIC 635
11 GRAPHIC gjhsarxv5ee4000005.jpg GRAPHIC 722
12 GRAPHIC gjhsarxv5ee4000011.jpg GRAPHIC 631
13 GRAPHIC gjhsarxv5ee4000006.jpg GRAPHIC 635
14 GRAPHIC gjhsarxv5ee4000007.jpg GRAPHIC 647
15 GRAPHIC gjhsarxv5ee4000012.jpg GRAPHIC 631
  Complete submission text file 0001564590-21-006421.txt   162016
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253219 | Film No.: 21645995
SIC: 2834 Pharmaceutical Preparations